Brett, Alan
Bowes, Michael A.
Conaghan, Philip G.
Article History
Received: 12 July 2022
Accepted: 23 January 2023
First Online: 30 January 2023
Declarations
:
: The study is being conducted in compliance with the protocol, Good Clinical Practice (GCP), the Declaration of Helsinki, and the applicable ethical and legal regulatory requirements (for all countries involved), and is registered under ExternalRef removed nr: ExternalRef removed. This study involves human participants and was approved by Medisch ethische toetsingscommisscie van het UMC UtrechtID nr. 17/440. Participants gave informed consent to participate in the study before taking part.
: Not required.
: AB and MB are employees of Imorphics Ltd., a wholly owned subsidiary of Stryker Corporation. PC has done consultancy or speakers bureaus for AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Galapagos, GlaxoSmithKline, Grunenthal, Merck, Novartis, Pfizer, Stryker and UCB.